financetom
Business
financetom
/
Business
/
Landstar System Fiscal Q4 EPS Falls, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Landstar System Fiscal Q4 EPS Falls, Revenue Increases
Jan 29, 2025 2:19 PM

04:48 PM EST, 01/29/2025 (MT Newswires) -- Landstar System ( LSTR ) reported fiscal Q4 earnings Wednesday of $1.31 per diluted share, down from $1.62 a year earlier.

Analysts polled by FactSet expected $1.34.

Revenue in the three months ended Dec. 28 rose to $1.209 billion from $1.204 billion a year earlier.

Analysts surveyed by FactSet expected $1.2 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citigroup's shareholders approve 2024 pay for CEO, executives, new shares for grants
Citigroup's shareholders approve 2024 pay for CEO, executives, new shares for grants
May 25, 2025
NEW YORK, April 29 (Reuters) - A large majority of Citigroup ( C/PN ) shareholders has approved CEO's Jane Fraser's 33% pay increase to $34.5 million at a virtual annual meeting held on Tuesday, as well as the compensation for other senior executives. More than 91% of shareholders voted in favor of the compensation packages. All proposals by Citi's board...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AstraZeneca Halts Phase 3 Trial for Prostate Cancer Treatment Combination
AstraZeneca Halts Phase 3 Trial for Prostate Cancer Treatment Combination
May 25, 2025
10:27 AM EDT, 04/29/2025 (MT Newswires) -- AstraZeneca ( AZN ) halted its phase 3 trial for prostate cancer treatment Truqap based on the recommendation of an independent data monitoring committee. The trial, which evaluated the efficacy and safety of Truqap in combination with docetaxel and androgen-deprivation therapy in patients with metastatic castration-resistant prostate cancer, was deemed unlikely to achieve...
Coca-Cola Boasts Q1 EPS Beat As Revenue Jumps In Europe, Middle East And Africa
Coca-Cola Boasts Q1 EPS Beat As Revenue Jumps In Europe, Middle East And Africa
May 25, 2025
Coca-Cola Company ( KO ) shares are trading higher on Tuesday after the soft drink company released first-quarter 2025 earnings. According to the report: First-quarter sales declined 1.77% year-on-year to $11.1 billion, missing the analyst consensus estimate of $11.14 billion. Revenue performance included a 1% climb in concentrate sales and a 5% growth in price/mix. Unit case volume grew 2%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved